1. Home
  2. OCS vs RSKD Comparison

OCS vs RSKD Comparison

Compare OCS & RSKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • RSKD
  • Stock Information
  • Founded
  • OCS 2003
  • RSKD 2012
  • Country
  • OCS Switzerland
  • RSKD United States
  • Employees
  • OCS N/A
  • RSKD N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • RSKD EDP Services
  • Sector
  • OCS Health Care
  • RSKD Technology
  • Exchange
  • OCS Nasdaq
  • RSKD Nasdaq
  • Market Cap
  • OCS 689.8M
  • RSKD 620.0M
  • IPO Year
  • OCS N/A
  • RSKD 2021
  • Fundamental
  • Price
  • OCS $18.27
  • RSKD $4.46
  • Analyst Decision
  • OCS Strong Buy
  • RSKD Hold
  • Analyst Count
  • OCS 4
  • RSKD 8
  • Target Price
  • OCS $30.25
  • RSKD $5.66
  • AVG Volume (30 Days)
  • OCS 48.2K
  • RSKD 497.4K
  • Earning Date
  • OCS 05-07-2025
  • RSKD 05-14-2025
  • Dividend Yield
  • OCS N/A
  • RSKD N/A
  • EPS Growth
  • OCS N/A
  • RSKD N/A
  • EPS
  • OCS N/A
  • RSKD N/A
  • Revenue
  • OCS $757,024.00
  • RSKD $327,516,000.00
  • Revenue This Year
  • OCS $57.00
  • RSKD $5.88
  • Revenue Next Year
  • OCS $1,820.89
  • RSKD $10.69
  • P/E Ratio
  • OCS N/A
  • RSKD N/A
  • Revenue Growth
  • OCS N/A
  • RSKD 10.05
  • 52 Week Low
  • OCS $10.79
  • RSKD $3.94
  • 52 Week High
  • OCS $23.08
  • RSKD $6.65
  • Technical
  • Relative Strength Index (RSI)
  • OCS 52.53
  • RSKD 46.21
  • Support Level
  • OCS $14.00
  • RSKD $4.38
  • Resistance Level
  • OCS $16.39
  • RSKD $4.51
  • Average True Range (ATR)
  • OCS 0.94
  • RSKD 0.22
  • MACD
  • OCS 0.22
  • RSKD 0.02
  • Stochastic Oscillator
  • OCS 71.40
  • RSKD 61.18

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About RSKD Riskified Ltd.

Riskified Ltd has built a next-generation eCommerce risk management platform that allows online merchants to create trusted relationships with their consumers. It generates revenue by granting merchants access to its eCommerce risk management platform and reviewing and approving eCommerce transactions for legitimacy. Its merchants include some of the ecommerce brands including Wayfair, Lastminute.com, SHEIN, and Macy's. Its merchants operate in a variety of verticals, including Payments, Money Transfer & Crypto, Tickets & Travel, Electronics, Home, Fashion & Luxury Goods, General Retail and Food. The company derived maximum revenue from Israel.

Share on Social Networks: